CVS Health Reports Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
CVS Health (CVS) PT Raised to $100 at RBC Capital
November 7, 2018 7:11 AM ESTRBC Capital analyst George Hill raised the price target on CVS Health (NYSE: CVS) to $100.00 (from $99.00) while maintaining a Outperform rating.
... MoreCVS Health (CVS) Tops Q3 EPS by 2c
November 6, 2018 6:56 AM ESTCVS Health (NYSE: CVS) reported Q3 EPS of $1.73, $0.02 better than the analyst estimate of $1.71. Revenue for the quarter came in at $47.3 billion versus the consensus estimate of $47.2 billion.
GUIDANCE:
CVS Health sees FY2018 EPS of $6.98-$7.08, versus the consensus of... More



